Eligibility for HFpEF and HFmrEF outcome trials and mortality risk in a cohort of decompensated heart failure patients. Do trial cohorts match with reality?

Back

HFA Premium Access

Eligibility for HFpEF and HFmrEF outcome trials and mortality risk in a cohort of decompensated heart failure patients. Do trial cohorts match with reality?

Session: HFpEF: only one disease?

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor V. Santner (Graz, AT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Viktoria Santner

University Hospital Graz, Graz (Austria)

0 follower

5 more presentations in this session

Prognostic implications of impaired glucose metabolism and albuminuria in heart failure with preserved ejection fraction

Speaker: Mr J. Weerts (Maastricht, NL)

Heart failure with preserved ejection fraction or non-cardiac dyspnea in paroxysmal atrial fibrillation: the role of left atrial strain

Speaker: Doctor A. Katbeh (Damascus, SY)

Heart failure with preserved ejection fraction in the elderly: when to suspect transthyrretin cardiac amyloidosis?

Speaker: Doctor C. Goena Vives (Donostia, ES)

Machine learning to identify patients response to spironolactone treatment in patients with heart failure with preserved ejection fraction

Speaker: Doctor K. Kresoja (Leipzig, DE)

Right ventricular form and function in heart failure with preserved ejection fraction. The HFpEF PHT Study.

Speaker: Doctor K. Rommel (Leipzig, DE)

Access the full session

HFpEF: only one disease?

Speakers: Doctor V. Santner, Mr J. Weerts, Doctor A. Katbeh, Doctor C. Goena Vives, Doctor K. Kresoja...

Access

Video

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources